William Oh

61.8k total citations · 14 hit papers
823 papers, 40.6k citations indexed

About

William Oh is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, William Oh has authored 823 papers receiving a total of 40.6k indexed citations (citations by other indexed papers that have themselves been cited), including 468 papers in Pulmonary and Respiratory Medicine, 256 papers in Pediatrics, Perinatology and Child Health and 140 papers in Surgery. Recurrent topics in William Oh's work include Prostate Cancer Treatment and Research (207 papers), Neonatal Respiratory Health Research (175 papers) and Neonatal Health and Biochemistry (80 papers). William Oh is often cited by papers focused on Prostate Cancer Treatment and Research (207 papers), Neonatal Respiratory Health Research (175 papers) and Neonatal Health and Biochemistry (80 papers). William Oh collaborates with scholars based in United States, Germany and Spain. William Oh's co-authors include Barbara J. Stoll, Richard A. Ehrenkranz, Seetha Shankaran, Avroy A. Fanaroff, James A. Lemons, Linda L. Wright, Jon E. Tyson, Matthew D. Galsky, David K. Stevenson and Philip W. Kantoff and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

William Oh

796 papers receiving 38.8k citations

Hit Papers

Whole-Body Hypothermia fo... 1973 2026 1990 2008 2005 2002 2009 2001 2007 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Whole-Body Hypothermia for Neonates with Hypoxic–Ischemic Encephalopathy
    2005 2.1k citations Seetha Shankaran, Richard A. Ehrenkranz et al. profile →
  2. Late-Onset Sepsis in Very Low Birth Weight Neonates: The Experience of the NICHD Neonatal Research Network
    2002 1.8k citations Avroy A. Fanaroff, Linda L. Wright et al. PEDIATRICS profile →
  3. Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
    2009 1.5k citations Wanling Xie, Meredith M. Regan et al. Journal of Clinical Oncology profile →
  4. Very Low Birth Weight Outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 Through December 1996
    2001 1.1k citations Charles R. Bauer, William Oh et al. PEDIATRICS profile →
  5. Trends in neonatal morbidity and mortality for very low birthweight infants
    2007 819 citations Richard A. Ehrenkranz, William Oh et al. profile →
  6. Treatment of muscle‐invasive and advanced bladder cancer in 2020
    2020 693 citations Vaibhav G. Patel, William Oh et al. profile →
  7. Late-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network
    1996 692 citations Sheldon B. Korones, Seetha Shankaran et al. The Journal of Pediatrics profile →
  8. Longitudinal Growth of Hospitalized Very Low Birth Weight Infants
    1999 637 citations Richard A. Ehrenkranz, Avroy A. Fanaroff et al. PEDIATRICS profile →
  9. Changes in Pathogens Causing Early-Onset Sepsis in Very-Low-Birth-Weight Infants
    2002 583 citations Avroy A. Fanaroff, Linda L. Wright et al. profile →
  10. Oral Probiotics Reduce the Incidence and Severity of Necrotizing Enterocolitis in Very Low Birth Weight Infants
    2005 500 citations William Oh et al. PEDIATRICS profile →
  11. Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy
    2011 457 citations Matthew D. Galsky, Guru Sonpavde et al. Journal of Clinical Oncology profile →
  12. Neonatal Candidiasis Among Extremely Low Birth Weight Infants: Risk Factors, Mortality Rates, and Neurodevelopmental Outcomes at 18 to 22 Months
    2006 456 citations William Oh et al. PEDIATRICS profile →
  13. Prenatal and intrapartum high-risk screening
    1973 335 citations William Oh et al. profile →
  14. Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes
    2021 238 citations William Oh et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
William Oh 20.3k 13.0k 7.5k 6.3k 5.1k 823 40.6k
Russell P. Tracy 8.6k 0.4× 1.8k 0.1× 13.3k 1.8× 7.9k 1.3× 19.5k 3.8× 674 87.8k
Nader Rifai 6.4k 0.3× 2.6k 0.2× 21.1k 2.8× 9.2k 1.5× 21.7k 4.2× 455 77.6k
Wim C.J. Hop 11.6k 0.6× 2.8k 0.2× 16.4k 2.2× 2.1k 0.3× 5.8k 1.1× 668 40.1k
Roger Bouillon 4.3k 0.2× 2.3k 0.2× 4.9k 0.7× 8.2k 1.3× 5.8k 1.1× 585 46.0k
David S. Celermajer 14.1k 0.7× 1.9k 0.1× 8.5k 1.1× 4.0k 0.6× 9.4k 1.8× 672 46.2k
Peter G. Gibson 22.0k 1.1× 1.3k 0.1× 6.9k 0.9× 5.8k 0.9× 6.2k 1.2× 1.0k 53.2k
Charles S. Fuchs 9.5k 0.5× 1.6k 0.1× 9.1k 1.2× 15.4k 2.4× 7.0k 1.4× 721 58.8k
Emiel F.�M. Wouters 27.1k 1.3× 1.3k 0.1× 2.0k 0.3× 4.9k 0.8× 3.4k 0.7× 705 41.5k
Børge G. Nordestgaard 8.8k 0.4× 1.4k 0.1× 27.1k 3.6× 7.8k 1.2× 10.4k 2.0× 953 65.2k
Steven J. Jacobsen 9.7k 0.5× 1.9k 0.1× 7.3k 1.0× 3.3k 0.5× 7.6k 1.5× 676 51.4k

Countries citing papers authored by William Oh

Since Specialization
Citations

This map shows the geographic impact of William Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Oh more than expected).

Fields of papers citing papers by William Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Oh. The network helps show where William Oh may publish in the future.

Co-authorship network of co-authors of William Oh

This figure shows the co-authorship network connecting the top 25 collaborators of William Oh. A scholar is included among the top collaborators of William Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Oh. William Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanders, JE, Lucas J. Brand, William L. Dahut, et al.. (2025). Consensus‐built recommendations to improve prostate cancer outcomes: A summary of the American Cancer Society Prostate Cancer Collaborative. Cancer. 131(16). e70010–e70010. 1 indexed citations
2.
Liu, Zongzhi, David Corrigan, Iftekhar Kalsekar, et al.. (2025). Decoding Recurrence in Early-Stage and Locoregionally Advanced Non–Small Cell Lung Cancer: Insights From Electronic Health Records and Natural Language Processing. JCO Clinical Cancer Informatics. 9(9). e2400227–e2400227.
3.
4.
Patel, Vaibhav G., Deepak Kumar Singh, Himanshu Joshi, et al.. (2024). Abstract CT223: Dormancy reprograming therapy of 5-azacitidine (AZA) and all-trans retinoic acid (ATRA) in biochemically recurrent prostate cancer. Cancer Research. 84(7_Supplement). CT223–CT223. 2 indexed citations
5.
Liu, Zongzhi, Tomi Jun, Meng Ma, et al.. (2024). Optimizing Clinical Trial Eligibility Design Using Natural Language Processing Models and Real-World Data: Algorithm Development and Validation. PubMed Central. 3. e50800–e50800. 2 indexed citations
6.
Liu, Zongzhi, Urmila Chandran, Iftekhar Kalsekar, et al.. (2023). Detecting Ground Glass Opacity Features in Patients With Lung Cancer: Automated Extraction and Longitudinal Analysis via Deep Learning–Based Natural Language Processing. SHILAP Revista de lepidopterología. 2. e44537–e44537. 6 indexed citations
7.
Qin, Qian, Tomi Jun, Bo Wang, et al.. (2022). Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis. Discover Oncology. 13(1). 73–73. 6 indexed citations
8.
Gong, Yixuan, Li Wang, Naomi Alpert, et al.. (2019). Prostate Cancer in World Trade Center Responders Demonstrates Evidence of an Inflammatory Cascade. Molecular Cancer Research. 17(8). 1605–1612. 20 indexed citations
9.
Saenger, Yvonne M., Jay Magidson, Yichun Fu, et al.. (2014). Blood mRNA Expression Profiling Predicts Survival in Patients Treated with Tremelimumab. Clinical Cancer Research. 20(12). 3310–3318. 31 indexed citations
10.
Pomerantz, Mark M., Lillian Werner, Wanling Xie, et al.. (2011). Association of Prostate Cancer Risk Loci with Disease Aggressiveness and Prostate Cancer–Specific Mortality. Cancer Prevention Research. 4(5). 719–728. 32 indexed citations
11.
Sun, Tong, William Oh, Susanna Jacobus, et al.. (2011). The Impact of Common Genetic Variations in Genes of the Sex Hormone Metabolic Pathways on Steroid Hormone Levels and Prostate Cancer Aggressiveness. Cancer Prevention Research. 4(12). 2044–2050. 24 indexed citations
12.
Galsky, Matthew D., William Oh, Joaquim Bellmunt, et al.. (2011). Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma. Annals of Oncology. 23(2). 406–410. 210 indexed citations
13.
Penney, Kathryn L., Saumyadipta Pyne, Fredrick R. Schumacher, et al.. (2010). Genome-wide Association Study of Prostate Cancer Mortality. Cancer Epidemiology Biomarkers & Prevention. 19(11). 2869–2876. 38 indexed citations
14.
Penney, Kathryn L., Claudia A. Salinas, Mark M. Pomerantz, et al.. (2009). Evaluation of 8q24 and 17q Risk Loci and Prostate Cancer Mortality. Clinical Cancer Research. 15(9). 3223–3230. 42 indexed citations
15.
Ross, Robert W., William Oh, Wanling Xie, et al.. (2008). Inherited Variation in the Androgen Pathway Is Associated With the Efficacy of Androgen-Deprivation Therapy in Men With Prostate Cancer. Journal of Clinical Oncology. 26(6). 842–847. 90 indexed citations
16.
Febbo, Phillip G., Aaron R. Thorner, Mark A. Rubin, et al.. (2006). Application of Oligonucleotide Microarrays to Assess the Biological Effects of Neoadjuvant Imatinib Mesylate Treatment for Localized Prostate Cancer. Clinical Cancer Research. 12(1). 152–158. 20 indexed citations
17.
Mercer, Judith, Betty R. Vohr, Margaret McGrath, et al.. (2006). Delayed Cord Clamping in Very Preterm Infants Reduces the Incidence of Intraventricular Hemorrhage and Late-Onset Sepsis: A Randomized, Controlled Trial. PEDIATRICS. 117(4). 1235–1242. 261 indexed citations
18.
Ment, Laura R., William Oh, Richard A. Ehrenkranz, et al.. (1994). Low-dose indomethacin therapy and extension of intraventricular hemorrhage: A multicenter randomized trial. The Journal of Pediatrics. 124(6). 951–955. 88 indexed citations
19.
Wright, Linda L., Roger F. Soll, Elizabeth C. Wright, et al.. (1993). A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome1. The Journal of Pediatrics. 123(5). 757–766. 124 indexed citations
20.
Ment, Laura R., William Oh, Alistair G.S. Philip, et al.. (1992). Risk factors for early intraventricular hemorrhage in low birth weight infants. The Journal of Pediatrics. 121(5). 776–783. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Russell P. Tracy Breakdown of academic impact, for papers by Nader Rifai Breakdown of academic impact, for papers by Wim C.J. Hop Breakdown of academic impact, for papers by Roger Bouillon Breakdown of academic impact, for papers by David S. Celermajer Breakdown of academic impact, for papers by Peter G. Gibson Breakdown of academic impact, for papers by Charles S. Fuchs Breakdown of academic impact, for papers by Emiel F.�M. Wouters Breakdown of academic impact, for papers by Børge G. Nordestgaard Breakdown of academic impact, for papers by Steven J. Jacobsen
Rankless by CCL
2026